Cover Image
Market Research Report
Product code
957692

Cell Expansion

Published: | Global Industry Analysts, Inc. | 205 Pages | Delivery time: 1-2 business days

Price

Back to Top
Cell Expansion
Published: April 1, 2021
Global Industry Analysts, Inc.
Content info: 205 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

Abstract:

Global Cell Expansion Market to Reach $27.9 Billion by 2027

Amid the COVID-19 crisis, the global market for Cell Expansion estimated at US$11.4 Billion in the year 2020, is projected to reach a revised size of US$27.9 Billion by 2027, growing at a CAGR of 13.6% over the analysis period 2020-2027. Instruments, one of the segments analyzed in the report, is projected to record a 12.8% CAGR and reach US$10 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Consumables segment is readjusted to a revised 14.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $3.4 Billion, While China is Forecast to Grow at 13.2% CAGR

The Cell Expansion market in the U.S. is estimated at US$3.4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.9 Billion by the year 2027 trailing a CAGR of 13.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.2% and 11.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10% CAGR.

Disposables Segment to Record 13.9% CAGR

In the global Disposables segment, USA, Canada, Japan, China and Europe will drive the 13.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2.1 Billion in the year 2020 will reach a projected size of US$5.1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.3 Billion by the year 2027.

Select Competitors (Total 41 Featured) -

  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Corning, Inc.
  • GE Healthcare
  • Lonza Group Ltd.
  • Merck KgaA
  • MilliporeSigma
  • Miltenyi Biotec GmbH
  • StemCell Technologies Inc.
  • Terumo BCT, Inc.
  • Thermo Fisher Scientific, Inc.
Table of Contents
Product Code: MCP10941

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Cell Expansion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 2: World 7-Year Perspective for Cell Expansion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
    • TABLE 3: World Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 4: World 7-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 5: World Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 6: World 7-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Disposables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 8: World 7-Year Perspective for Disposables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 9: World Current & Future Analysis for Human Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 10: World 7-Year Perspective for Human Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 11: World Current & Future Analysis for Animal Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 12: World 7-Year Perspective for Animal Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Regenerative Medicine & Stem Cell Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 14: World 7-Year Perspective for Regenerative Medicine & Stem Cell Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 15: World Current & Future Analysis for Cancer & Cell-based Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 16: World 7-Year Perspective for Cancer & Cell-based Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 17: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 18: World 7-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 20: World 7-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 21: World Current & Future Analysis for Biopharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 22: World 7-Year Perspective for Biopharmaceutical & Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 23: World Current & Future Analysis for Cell Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 24: World 7-Year Perspective for Cell Banks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 25: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 26: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 27: USA Current & Future Analysis for Cell Expansion by Product Type - Instruments, Consumables and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 28: USA 7-Year Perspective for Cell Expansion by Product Type - Percentage Breakdown of Value Sales for Instruments, Consumables and Disposables for the Years 2020 & 2027
    • TABLE 29: USA Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 30: USA 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2020 & 2027
    • TABLE 31: USA Current & Future Analysis for Cell Expansion by Application - Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 32: USA 7-Year Perspective for Cell Expansion by Application - Percentage Breakdown of Value Sales for Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research and Other Applications for the Years 2020 & 2027
    • TABLE 33: USA Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Biopharmaceutical & Biotechnology Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 34: USA 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Biopharmaceutical & Biotechnology Companies, Cell Banks and Other End-Uses for the Years 2020 & 2027
  • CANADA
    • TABLE 35: Canada Current & Future Analysis for Cell Expansion by Product Type - Instruments, Consumables and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 36: Canada 7-Year Perspective for Cell Expansion by Product Type - Percentage Breakdown of Value Sales for Instruments, Consumables and Disposables for the Years 2020 & 2027
    • TABLE 37: Canada Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Canada 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2020 & 2027
    • TABLE 39: Canada Current & Future Analysis for Cell Expansion by Application - Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 40: Canada 7-Year Perspective for Cell Expansion by Application - Percentage Breakdown of Value Sales for Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research and Other Applications for the Years 2020 & 2027
    • TABLE 41: Canada Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Biopharmaceutical & Biotechnology Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 42: Canada 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Biopharmaceutical & Biotechnology Companies, Cell Banks and Other End-Uses for the Years 2020 & 2027
  • JAPAN
    • TABLE 43: Japan Current & Future Analysis for Cell Expansion by Product Type - Instruments, Consumables and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Japan 7-Year Perspective for Cell Expansion by Product Type - Percentage Breakdown of Value Sales for Instruments, Consumables and Disposables for the Years 2020 & 2027
    • TABLE 45: Japan Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 46: Japan 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2020 & 2027
    • TABLE 47: Japan Current & Future Analysis for Cell Expansion by Application - Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 48: Japan 7-Year Perspective for Cell Expansion by Application - Percentage Breakdown of Value Sales for Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research and Other Applications for the Years 2020 & 2027
    • TABLE 49: Japan Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Biopharmaceutical & Biotechnology Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 50: Japan 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Biopharmaceutical & Biotechnology Companies, Cell Banks and Other End-Uses for the Years 2020 & 2027
  • CHINA
    • TABLE 51: China Current & Future Analysis for Cell Expansion by Product Type - Instruments, Consumables and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 52: China 7-Year Perspective for Cell Expansion by Product Type - Percentage Breakdown of Value Sales for Instruments, Consumables and Disposables for the Years 2020 & 2027
    • TABLE 53: China Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 54: China 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2020 & 2027
    • TABLE 55: China Current & Future Analysis for Cell Expansion by Application - Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 56: China 7-Year Perspective for Cell Expansion by Application - Percentage Breakdown of Value Sales for Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research and Other Applications for the Years 2020 & 2027
    • TABLE 57: China Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Biopharmaceutical & Biotechnology Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 58: China 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Biopharmaceutical & Biotechnology Companies, Cell Banks and Other End-Uses for the Years 2020 & 2027
  • EUROPE
    • TABLE 59: Europe Current & Future Analysis for Cell Expansion by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 60: Europe 7-Year Perspective for Cell Expansion by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
    • TABLE 61: Europe Current & Future Analysis for Cell Expansion by Product Type - Instruments, Consumables and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 62: Europe 7-Year Perspective for Cell Expansion by Product Type - Percentage Breakdown of Value Sales for Instruments, Consumables and Disposables for the Years 2020 & 2027
    • TABLE 63: Europe Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 64: Europe 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2020 & 2027
    • TABLE 65: Europe Current & Future Analysis for Cell Expansion by Application - Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 66: Europe 7-Year Perspective for Cell Expansion by Application - Percentage Breakdown of Value Sales for Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research and Other Applications for the Years 2020 & 2027
    • TABLE 67: Europe Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Biopharmaceutical & Biotechnology Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Europe 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Biopharmaceutical & Biotechnology Companies, Cell Banks and Other End-Uses for the Years 2020 & 2027
  • FRANCE
    • TABLE 69: France Current & Future Analysis for Cell Expansion by Product Type - Instruments, Consumables and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 70: France 7-Year Perspective for Cell Expansion by Product Type - Percentage Breakdown of Value Sales for Instruments, Consumables and Disposables for the Years 2020 & 2027
    • TABLE 71: France Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 72: France 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2020 & 2027
    • TABLE 73: France Current & Future Analysis for Cell Expansion by Application - Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 74: France 7-Year Perspective for Cell Expansion by Application - Percentage Breakdown of Value Sales for Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research and Other Applications for the Years 2020 & 2027
    • TABLE 75: France Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Biopharmaceutical & Biotechnology Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 76: France 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Biopharmaceutical & Biotechnology Companies, Cell Banks and Other End-Uses for the Years 2020 & 2027
  • GERMANY
    • TABLE 77: Germany Current & Future Analysis for Cell Expansion by Product Type - Instruments, Consumables and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 78: Germany 7-Year Perspective for Cell Expansion by Product Type - Percentage Breakdown of Value Sales for Instruments, Consumables and Disposables for the Years 2020 & 2027
    • TABLE 79: Germany Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 80: Germany 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2020 & 2027
    • TABLE 81: Germany Current & Future Analysis for Cell Expansion by Application - Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 82: Germany 7-Year Perspective for Cell Expansion by Application - Percentage Breakdown of Value Sales for Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research and Other Applications for the Years 2020 & 2027
    • TABLE 83: Germany Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Biopharmaceutical & Biotechnology Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 84: Germany 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Biopharmaceutical & Biotechnology Companies, Cell Banks and Other End-Uses for the Years 2020 & 2027
  • ITALY
    • TABLE 85: Italy Current & Future Analysis for Cell Expansion by Product Type - Instruments, Consumables and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Italy 7-Year Perspective for Cell Expansion by Product Type - Percentage Breakdown of Value Sales for Instruments, Consumables and Disposables for the Years 2020 & 2027
    • TABLE 87: Italy Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 88: Italy 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2020 & 2027
    • TABLE 89: Italy Current & Future Analysis for Cell Expansion by Application - Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 90: Italy 7-Year Perspective for Cell Expansion by Application - Percentage Breakdown of Value Sales for Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research and Other Applications for the Years 2020 & 2027
    • TABLE 91: Italy Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Biopharmaceutical & Biotechnology Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Italy 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Biopharmaceutical & Biotechnology Companies, Cell Banks and Other End-Uses for the Years 2020 & 2027
  • UNITED KINGDOM
    • TABLE 93: UK Current & Future Analysis for Cell Expansion by Product Type - Instruments, Consumables and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 94: UK 7-Year Perspective for Cell Expansion by Product Type - Percentage Breakdown of Value Sales for Instruments, Consumables and Disposables for the Years 2020 & 2027
    • TABLE 95: UK Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 96: UK 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2020 & 2027
    • TABLE 97: UK Current & Future Analysis for Cell Expansion by Application - Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 98: UK 7-Year Perspective for Cell Expansion by Application - Percentage Breakdown of Value Sales for Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research and Other Applications for the Years 2020 & 2027
    • TABLE 99: UK Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Biopharmaceutical & Biotechnology Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 100: UK 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Biopharmaceutical & Biotechnology Companies, Cell Banks and Other End-Uses for the Years 2020 & 2027
  • REST OF EUROPE
    • TABLE 101: Rest of Europe Current & Future Analysis for Cell Expansion by Product Type - Instruments, Consumables and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 102: Rest of Europe 7-Year Perspective for Cell Expansion by Product Type - Percentage Breakdown of Value Sales for Instruments, Consumables and Disposables for the Years 2020 & 2027
    • TABLE 103: Rest of Europe Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 104: Rest of Europe 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2020 & 2027
    • TABLE 105: Rest of Europe Current & Future Analysis for Cell Expansion by Application - Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 106: Rest of Europe 7-Year Perspective for Cell Expansion by Application - Percentage Breakdown of Value Sales for Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research and Other Applications for the Years 2020 & 2027
    • TABLE 107: Rest of Europe Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Biopharmaceutical & Biotechnology Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 108: Rest of Europe 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Biopharmaceutical & Biotechnology Companies, Cell Banks and Other End-Uses for the Years 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 109: Asia-Pacific Current & Future Analysis for Cell Expansion by Product Type - Instruments, Consumables and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 110: Asia-Pacific 7-Year Perspective for Cell Expansion by Product Type - Percentage Breakdown of Value Sales for Instruments, Consumables and Disposables for the Years 2020 & 2027
    • TABLE 111: Asia-Pacific Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 112: Asia-Pacific 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2020 & 2027
    • TABLE 113: Asia-Pacific Current & Future Analysis for Cell Expansion by Application - Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 114: Asia-Pacific 7-Year Perspective for Cell Expansion by Application - Percentage Breakdown of Value Sales for Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research and Other Applications for the Years 2020 & 2027
    • TABLE 115: Asia-Pacific Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Biopharmaceutical & Biotechnology Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 116: Asia-Pacific 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Biopharmaceutical & Biotechnology Companies, Cell Banks and Other End-Uses for the Years 2020 & 2027
  • REST OF WORLD
    • TABLE 117: Rest of World Current & Future Analysis for Cell Expansion by Product Type - Instruments, Consumables and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 118: Rest of World 7-Year Perspective for Cell Expansion by Product Type - Percentage Breakdown of Value Sales for Instruments, Consumables and Disposables for the Years 2020 & 2027
    • TABLE 119: Rest of World Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 120: Rest of World 7-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2020 & 2027
    • TABLE 121: Rest of World Current & Future Analysis for Cell Expansion by Application - Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 122: Rest of World 7-Year Perspective for Cell Expansion by Application - Percentage Breakdown of Value Sales for Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research and Other Applications for the Years 2020 & 2027
    • TABLE 123: Rest of World Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Biopharmaceutical & Biotechnology Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 124: Rest of World 7-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Biopharmaceutical & Biotechnology Companies, Cell Banks and Other End-Uses for the Years 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 41